Paul Brannelly
2018 - Collegium Pharmaceutical
In 2018, Paul Brannelly earned a total compensation of $2M as Executive Vice President and Chief Financial Officer at Collegium Pharmaceutical, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $222,500 |
|---|---|
| Option Awards | $739,268 |
| Salary | $387,692 |
| Stock Awards | $608,750 |
| Other | $17,294 |
| Total | $1,975,504 |
Brannelly received $739.3K in option awards, accounting for 37% of the total pay in 2018.
Brannelly also received $222.5K in non-equity incentive plan, $387.7K in salary, $608.8K in stock awards and $17.3K in other compensation.
Rankings
In 2018, Paul Brannelly's compensation ranked 5,817th out of 14,244 executives tracked by ExecPay. In other words, Brannelly earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,817 out of 14,244 | 59th |
Division Manufacturing | 2,205 out of 5,759 | 62nd |
Major group Chemicals And Allied Products | 818 out of 2,122 | 62nd |
Industry group Drugs | 684 out of 1,811 | 62nd |
Industry Pharmaceutical Preparations | 531 out of 1,385 | 62nd |
Source: SEC filing on March 15, 2019.
Brannelly's colleagues
We found five more compensation records of executives who worked with Paul Brannelly at Collegium Pharmaceutical in 2018.
2018
Michael Ph
Collegium Pharmaceutical
Founder
2018
Joseph Ciaffoni
Collegium Pharmaceutical
Chief Executive Officer
2018
Scott Dreyer
Collegium Pharmaceutical
Executive Vice President and Chief Commercial Officer
2018
Alison Fleming
Collegium Pharmaceutical
Chief Technology Officer
2018
Shirley Kuhlmann
Collegium Pharmaceutical